2005•Zhonghua fengshibingxue zazhiRequires access

Clinical significance of urine MCP-1 determination in patients with lupus nephritis

Shi Yong-ju

Open publisher page 0 citations

Abstract

Objective To explore the clinical significance of urine monocyte chemoattractant protein-1 (MCP-1) in patients with lupus nephritis (LN). Methods Urine MCP-1 was detected by Enzyme-linked immunosorbent assay (ELISA). Correlation analysis of urine MCP-1 and renal injury, urine MCP-1 and the activity indices of renal histopathologic change were evaluated. Results Urine MCP-1 level in LN patients (1130±403) pg/mg Cr was significantly higher than that of normal controls (141±109) pg/(mgCr) (P0.01) and primary nephritis patients (452±174) pg/mg Cr (P0.01). Urine MCP-I was significantly correlated with proteinuria (r=0.558, P0.05), serum creatinine level (r=0.869, P0.01), urine NAG (r=0.617, P0.05) and the activity indices (AI) of renal histopathologic change (r=0.751, P0.01). Conclusion Urine MCP-1 can be used as a molecular maker to evaluate disease activity of patients with lupus nephritis.

About this research paper

What this paper is about

Objective To explore the clinical significance of urine monocyte chemoattractant protein-1 (MCP-1) in patients with lupus nephritis (LN). Methods Urine MCP-1 was detected by Enzyme-linked immunosorbent assay (ELISA). Correlation analysis of urine MCP-1 and renal injury, urine MCP-1 and the activity indices of renal histopathologic change were evaluated. Results Urine MCP-1 level in LN patients (1130±403) pg/mg Cr was significantly higher than that of normal controls (141±109) pg/(mgCr) (P0.01) and primary nephritis patients (452±174) pg/mg Cr (P0.01). Urine MCP-I was significantly correlated with proteinuria (r=0.558, P0.05), serum creatinine level (r=0.869, P0.01), urine NAG (r=0.617, P0.05) and the activity indices (AI) of renal histopathologic change (r=0.751, P0.01). Conclusion Urine MCP-1 can be used as a molecular maker to evaluate disease activity of patients with lupus nephritis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical significance of urine monocyte chemoattractant protein-1 (MCP-1) in patients with lupus nephritis (LN). Methods Urine MCP-1 was detected by Enzyme-linked immunosorbent assay (ELISA). Correlation analysis of urine MCP-1 and renal injury, urine MCP-1 and the activity indices of renal histopathologic change were evaluated. Results Urine MCP-1 level in LN patients (1130±403) pg/mg Cr was significantly higher than that of normal controls (141±109) pg/(mgCr) (P0.01) and primary nephritis patients (452±174) pg/mg Cr (P0.01). Urine MCP-I was significantly correlated with proteinuria (r=0.558, P0.05), serum creatinine level (r=0.869, P0.01), urine NAG (r=0.617, P0.05) and the activity indices (AI) of renal histopathologic change (r=0.751, P0.01). Conclusion Urine MCP-1 can be used as a molecular maker to evaluate disease activity of patients with lupus nephritis.

Key concepts: Urine, Lupus nephritis, Medicine, Proteinuria, Nephritis, Internal medicine, Creatinine, Clinical significance

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance of urine MCP-1 determination in patients with lupus nephritis — Research Paper | ScholarLens